Aion Therapeutic Inc.
ANTCF
$0.006
-$0.006-50.00%
| 01/31/2024 | 10/31/2023 | 07/31/2023 | 04/30/2023 | 01/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -279.90K | -187.80K | -191.10K | -534.10K | -160.00K |
| Total Depreciation and Amortization | 11.10K | -- | -- | 100.00 | 4.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 35.40K | 23.50K | 23.90K | 474.80K | -70.00K |
| Change in Net Operating Assets | 413.60K | 61.40K | 62.50K | 171.20K | 136.80K |
| Cash from Operations | 180.20K | -102.90K | -104.70K | 111.90K | -88.90K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 0.00 | 100.30K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -17.30K | -98.00K | -99.70K | -- | -- |
| Cash from Investing | -17.30K | -98.00K | -99.70K | 0.00 | 100.30K |
| Total Debt Issued | 35.00K | -- | -- | 1.00K | 18.40K |
| Total Debt Repaid | -12.20K | -- | -- | -100.00 | -141.70K |
| Issuance of Common Stock | 0.00 | 271.30K | 271.30K | 0.00 | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 25.90K | -- | -- | -- | -- |
| Cash from Financing | 36.10K | 199.70K | 203.30K | 600.00 | -91.50K |
| Foreign Exchange rate Adjustments | 59.10K | 1.30K | 1.30K | -112.30K | 70.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 258.00K | 200.00 | 200.00 | 200.00 | -10.00K |
